Industry is struggling to attract talent, as science, technology, engineering and maths representation worsens - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/stem_sellClosing the healthcare inequity gap throughout our communities is essential - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/chat_roomWhy we must protect and accelerate the innovation that creates life-saving treatments - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/human_leagueWhat is the future of retinal healthcare and how do we ensure it incorporates healthy equity? - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/in_our_sightsDiabetes is still a global crisis and one we need to urgently address - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/killer_at_largeIntelligent resourcing – what it means and why it’s important for companies - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/the_force_awakensBy working in partnership the NHS is getting more innovative treatments to patients and faster - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/long_and_winding_roadAnalysing the worsening mental health landscape across Europe - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2022/december_2022/time_is_of_the_essenceClinical trial has received regulatory approval and involves endometriosis candidate SN132D - News - PharmaTimes
by John Pinching
https://www.pharmatimes.com/news/spago_nanomedical_begins_endometriosis_study_1482681The PharmaTimes portfolio includes the well-respected monthly PharmaTimes Magazine; three news elert services; business forums, where thought-leaders meet to discuss the issues of the day; and a series of awards that recognise, reward and celebrate
by PharmaTimes
https://www.pharmatimes.com/
